Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2961
Small font sizeDefault font sizeIncrease font size
Navigate here
  Search
 
 » Next article
 » Previous article 
 » Table of Contents
  
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (81 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

 
  In this article
 »  Abstract
 »  Introduction
 »  Case History
 »  Discussion
 »  References
 »  Article Figures
 »  Authors' contribution

 Article Access Statistics
    Viewed5815    
    Printed145    
    Emailed0    
    PDF Downloaded423    
    Comments [Add]    
    Cited by others 16    

Recommend this journal

 

CASE REPORT
Year : 2008  |  Volume : 45  |  Issue : 1  |  Page : 27-29
 

Pulmonary artery sarcoma mimicking a pulmonary embolism


1 Department of Internal Medicine, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI 48202, USA
2 Department of Hematology/Oncology, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI 48202, USA

Correspondence Address:
T J Yates
Department of Hematology/Oncology, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI 48202
USA
Login to access the Email id

Source of Support: Nil, Conflict of Interest: Nil


DOI: 10.4103/0019-509X.40643

Clinical trial registration Nil

Rights and Permissions

 » Abstract 

Sarcomas involving the lung are a rare occurrence, often a result of metastatic disease from primary malignancies involving the skin, liver, breast or heart. Primary pulmonary artery sarcomas are rarer still, with limited cases reported world-wide and consequently data regarding treatment modalities are sparse and largely experimental. These tumors are often mistaken for a pulmonary embolism and seemingly supported by radiological findings. Patients will often present without symptom resolution despite therapeutic anticoagulation. The following case illustrates how a soft tissue sarcoma of the pulmonary artery can mimic a pulmonary embolism, thus, resulting in both a diagnostic and therapeutic dilemma. A positron emission tomography scan was an invaluable tool in this case, showing increased radiotracer uptake and placing neoplasm at the top of the differential diagnosis. This ultimately led to a biopsy that was vimentin positive, cytokeratin negative and CD117 negative, thus consistent with soft tissue sarcoma.


Keywords: Positron emission tomography, pulmonary embolism, sarcoma


How to cite this article:
Sandhu A, Yates T J, Kuriakose P. Pulmonary artery sarcoma mimicking a pulmonary embolism. Indian J Cancer 2008;45:27-9

How to cite this URL:
Sandhu A, Yates T J, Kuriakose P. Pulmonary artery sarcoma mimicking a pulmonary embolism. Indian J Cancer [serial online] 2008 [cited 2020 Jul 10];45:27-9. Available from: http://www.indianjcancer.com/text.asp?2008/45/1/27/40643



 » Introduction Top


Soft tissue sarcomas involving the pulmonary artery are extremely rare and often go unrecognized. They may imitate the presentation of a pulmonary embolism, both clinically and radiologically, making the diagnosis difficult and potentially delaying treatment. The following case helps demonstrate how the utilization of a positron emission tomography (PET) scan allowed for our patient to be diagnosed and thus begin treatment for his underlying neoplastic process.


 » Case History Top


A 56-year-old gentleman presented to an outside Emergency Department with exertional shortness of breath. His past medical history included hepatitis C and hypothyroidism. A computed tomography (CT) scan revealed a saddle pulmonary embolism but no other abnormalities. He was anticoagulated with heparin and later discharged on warfarin. Thereafter, he remained well for approximately six weeks, at which time he again developed severe exertional dyspnea. A repeat CT scan ordered by his primary physician, showed extension of the clot, accompanied this time by the appearance of lung nodules [Figure - 1]. He was recommended discontinuation of warfarin and to be evaluated in hematology/oncology to rule out a neoplastic process.

When seen at our institution, his only complaint was ongoing exertional shortness of breath, with no associated hemoptysis, chest pain, cough, night sweats or loss of consciousness. His review of systems was otherwise non-contributory. On account of the suspicion of a possible neoplastic process, a PET scan was obtained, which revealed increased radiotracer uptake over the area of the presumed pulmonary thrombus, as well as other areas of the right lung, including a lower lobe sub pleural nodule [Figure - 2].

During his outpatient evaluation he developed two syncopal episodes, with associated exertional dyspnea and presented to our Emergency Department. His electrocardiogram showed ST elevations in leads V3-V5 along with a small elevation in the troponin I of 0.31 (normal is less than 0.20), indicative of cardiac damage. He was transferred to the cardiac intensive care unit where he was empirically started on aspirin, metoprolol, lisinopril and atorvastatin. His echocardiogram revealed an ejection fraction of 55-65%, aortic root dilatation, right ventricle dilatation, mild pulmonic regurgitation, normal right atrium, systolic pulmonary artery pressure of 33 mmHg and an echogenic mass in the pulmonary artery, with mild tricuspid regurgitation. He was taken to the catheterization lab and was found to have 30-31% stenosis in the left main coronary artery, consistent with non-ischemic cardiomyopathy.

Multidisciplinary team approach was initiated; a cardiothoracic approach was deemed to be too dangerous and so was an embolectomy. After much consideration, the patient underwent a CT guided biopsy of the right lower lobe nodule revealing a malignant tumor, consistent with a soft tissue sarcoma. The sarcoma was classified as high grade; however the exact subtype could not be determined. On immunohistochemistry, the tissue was vimentin positive, cytokeratin negative and CD117 negative, being thus consistent with a soft tissue sarcoma [Figure - 3]. Based on the site of initial involvement, a primary pulmonary artery sarcoma was suspected.

Based on the anatomical position and extent of his disease, surgery was not considered a realistic option and he was admitted for systemic chemotherapy using Mesna, Adriamycin, Ifosfamide and Dacarbazine (MAID). [1] He seemed to be responding after four cycles of therapy, as demonstrated on repeat imaging studies. However, following additional two cycles, he was found to have progressed. Following this, he was treated with single agent Gemcitabine, but continued to show evidence of progression. At this time, twelve months following his initial diagnosis, he enrolled in a clinical trial using ET 743.


 » Discussion Top


Sarcomas involving the lung are a rare occurrence, often a result of metastatic disease from primary malignancies involving the skin, liver, breast or heart. Primary pulmonary artery sarcomas are rarer still, with limited cases reported world wide and consequently data regarding treatment modalities are very sparse and largely experimental. They were initially described in 1923 by Mandelstamm. These tumors run an indolent course and often do not come to attention until there are symptoms of right outflow obstruction, including hemoptysis, dyspnea, cough, chest pain, swelling of the lower extremities and loss of consciousness. They are often mistaken for a pulmonary embolism and seemingly supported by radiological findings. [2],[3],[4],[5],[6],[7] These findings include a ventilation perfusion mismatch in the area of the pulmonary artery obstruction. CT scanning can also yield an imagery disguise and thus what appears to be a mass in the pulmonary artery is often mistaken for a pulmonary embolism. Thus, patients will often present without symptom resolution despite therapeutic anticoagulation. A repeat CT scan often shows an enlarging mass, with accompanying hilar masses. A PET scan can be an invaluable tool in this setting, showing increased radiotracer uptake in the mass. [7],[8],[9],[10]

Tumor embolization from the pulmonary artery is a commonly recognized phenomenon, presenting as distal metastases or worse still, as compromised blood flow to distal organs and structures. The prognosis is poor, with patients dying within months to a year of presentation. Surgery has been the accepted treatment modality of choice, although emerging data show that these tumors are radiosensitive. Interleukin 2 and Paclitaxel have also been noted to be beneficial in tumor regression and survival. [7],[11] Most of the data and evidence are largely experimental and due to case scarcity these studies are confined to isolated cases, without reproducible large scale trials. [12],[13],[14]

 
 » References Top

1.Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-85.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Delany SG, Doyle TC, Bunton RW, Hung NA, Joblin LU, Taylor DR. Pulmonary artery sarcoma mimicking pulmonary embolism. Chest 1993;103:1631-3.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Kerr KM. Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonary hypertension. Nat Clin Pract Cardiovasc Med 2005;2:108-22.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Miura S, Meirmanov S, Nakashima M, Hayashi T, Abe K, Tamaru N, et al. Intimal sarcoma of the pulmonary artery: Report of an autopsy case. Pathol Res Pract 2005;201:469-74.  Back to cited text no. 4  [PUBMED]  
5.Pandit SA, Fiedler PN, Westcott JL. Primary angiosarcoma of the lung. Ann Diagnost Pathol 2005;9:302-4.  Back to cited text no. 5    
6.Keel SB, Bacha E, Mark EJ, Nielsen GP, Rosenberg AE. Primary pulmonary sarcoma: A clinicopathologic study of 26 cases. Mod Pathol 1999;12:1124-31.  Back to cited text no. 6  [PUBMED]  
7.Kojima K, Okamoto I, Ushijima S, Yoshinaga T, Kitaoka M, Suga M, et al. Successful treatment of primary pulmonary angiosarcoma. Chest 2003;124:2397-400.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Britton PD. Primary pulmonary artery sarcoma: A report of two cases, with special emphasis on the diagnostic problems. Clin Radiol 1990;41:92-4.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]
9.Yamada N, Kamei S, Yasuda F, Isaka N, Yada I, Nakano T. Primary leiomyosarcoma of the pulmonary artery confirmed by catheter suction biopsy. Chest 1998;113:555-6.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]
10.Wright EC, Wellons HA, Martin RP. Primary pulmonary artery sarcoma diagnosed noninvasively by two- dimensional echocardiography. Circulation 1983;67:459-62.  Back to cited text no. 10  [PUBMED]  
11.Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999;86:2034-7.  Back to cited text no. 11  [PUBMED]  [FULLTEXT]
12.Etienne-Mastroianni B, Falchero L, Chalabreysse L, Loire R, Ranchθre D, Souquet PJ, et al. Primary sarcomas of the lung: A clinopathologic study of 12 cases. Lung Cancer 2002;38:283-9.  Back to cited text no. 12    
13.Corpa-Rodriguez ME, Mayoralas-Alises S, Garcia-Sanchez J, Gil-Alonso JL, Dνaz-Agero P, Casillas-Pajuelo M. Postoperative course in 7 cases of primary sarcoma of the lung. Arch Bronconeumol 2005;41:634-7.  Back to cited text no. 13    
14.Gross JL, Younes RN, Haddad FJ, Deheinzelin D, Pinto CA, Costa ML. Soft-tissue sarcomas of the chest wall: Prognostic factors. Chest 2005;127:902-8.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]


    Figures

  [Figure - 1], [Figure - 2], [Figure - 3]
 
    Authors' contribution

Sandhu A: Concepts,
Yates TJ: Concepts,
Kuriakose P: Concepts,

This article has been cited by
1 Value of 18F-FDG PET/CT in differentiating malignancy of pulmonary artery from pulmonary thromboembolism: a cohort study and literature review
Xiao-Ying Xi,Wei Gao,Juan-Ni Gong,Xiao-Juan Guo,Jiao-Yan Wu,Yuan-Hua Yang,Min-Fu Yang
The International Journal of Cardiovascular Imaging. 2019; 35(7): 1395
[Pubmed] | [DOI]
2 Dual-energy CT-based iodine quantification for differentiating pulmonary artery sarcoma from pulmonary thromboembolism: a pilot study
Suyon Chang,Jin Hur,Dong Jin Im,Young Joo Suh,Yoo Jin Hong,Hye-Jeong Lee,Young Jin Kim,Byoung Wook Choi
European Radiology. 2016; 26(9): 3162
[Pubmed] | [DOI]
3 Clinical features of pulmonary artery sarcoma: A report of three cases
Guangfa Zhu,Xin Pu,Hongjuang Guo,Xiaoyong Huang,Dong Chen,Huili Gan
Experimental and Therapeutic Medicine. 2016; 12(2): 1201
[Pubmed] | [DOI]
4 Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
Sumitra Shantakumar,Alexandra Connelly-Frost,Monica G Kobayashi,Robert Allis,Li Li
Clinical Sarcoma Research. 2015; 5(1)
[Pubmed] | [DOI]
5 Pseudo pulmonary embolism in cancer patients
Ophira Salomon,Yasmin Leshem,Iris Gluck,Ehud Grossman,Sara Apter,Eli Konen
Blood Coagulation & Fibrinolysis. 2014; 25(8): 871
[Pubmed] | [DOI]
6 Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism
Eun Jeong Lee,Seung Hwan Moon,Joon Young Choi,Kyung Soo Lee,Yong Soo Choi,Yearn Seong Choe,Kyung-Han Lee,Byung-Tae Kim
ANZ Journal of Surgery. 2013; 83(5): 342
[Pubmed] | [DOI]
7 Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism
Lee, E.J. and Moon, S.H. and Choi, J.Y. and Lee, K.S. and Choi, Y.S. and Choe, Y.S. and Lee, K.-H. and Kim, B.-T.
ANZ Journal of Surgery. 2013; 83(5): 342-347
[Pubmed]
8 Case 166: Metastatic Left Pulmonary Artery Sarcoma
Mittra, E.S., Iagaru, A.H., Leung, A.N.
Radiology. 2011; 258(2): 645-648
[Pubmed]
9 Case 166: Metastatic Left Pulmonary Artery Sarcoma
E. S. Mittra,A. H. Iagaru,A. N. Leung
Radiology. 2011; 258(2): 645
[Pubmed] | [DOI]
10 A Rare Reason for Pulmonary Hypertension: Primary Sarcoma of the Pulmonary Artery
Aysel Aydin Kaderli, İbrahim Baran, Saim Sağ, Murat Biçer, Sibel Aker
The Heart Surgery Forum. 2010; 13(1): E28-E30
[Pubmed] | [DOI]
11 Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism
Kimiteru Ito,Kazuo Kubota,Miyako Morooka,Yoshitaka Shida,Kanehiro Hasuo,Hisako Endo,Hiroshi Matsuda
Annals of Nuclear Medicine. 2009; 23(7): 671
[Pubmed] | [DOI]
12 Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism
Ito, K., Kubota, K., Morooka, M., Shida, Y., Hasuo, K., Endo, H., Matsuda, H.
Annals of Nuclear Medicine. 2009; 23(7): 671-676
[Pubmed]
13 Thromboembolism in Pulmonary Artery Sarcoma
Mohsen Farsad,Patrizia Pernter,Antonio Triani,Luzian Osele,Christian J. Wiedermann
Clinical Nuclear Medicine. 2009; 34(4): 239
[Pubmed] | [DOI]
14 Thromboembolism in Pulmonary Artery Sarcoma
Farsad, M. and Pernter, P. and Triani, A. and Osele, L. and Wiedermann, C.J.
Clinical Nuclear Medicine. 2009; 34(4): 239-240
[Pubmed]
15 Authorsæ reply
Sandhu, A., Yates, T., Kuriakose, P.
Indian Journal of Cancer. 2008; 45(2): 76-77
[Pubmed]
16 Pulmonary artery sarcoma: The hidden truth.
Das, S.
Indian J Cancer. 2008; 45(2): 76
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow